Literature DB >> 15008962

Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airways.

Osamu Nishiyama1, Hiroaki Kume, Masashi Kondo, Yasushi Ito, Masafumi Ito, Kenichi Yamaki.   

Abstract

1. Lysophosphatidylcholine (Lyso-PC), which is synthesized by phospholipase A2, is generally considered to induce adhesion molecules. However, little is known about the involvement of Lyso-PC in the pathogenesis of bronchial asthma. The present study was designed to examine whether pre-exposure to Lyso-PC causes eosinophil recruitment and an increase in resistance in airways. 2. Eosinophils in bronchoalveolar lavage fluid (BALF) and the airway walls were enumerated after inhalation of 0.5 mg/mL Lyso-PC to guinea-pigs for 10 min. Respiratory resistance (Rrs) was recorded continuously over 6 h after inhalation of an equi-dose of Lyso-PC for an equivalent period. 3. The proportion of eosinophils was increased from 10.7 +/- 3.3 to 27.5 +/- 3.1% (P < 0.0001) in BALF 6 h after inhalation of Lyso-PC, whereas the proportion of neutrophils and lymphocytes was not increased. Histological examination also showed uniform distribution of eosinophils in the airway wall of bronchi and bronchioles 6 h after inhalation of Lyso-PC. The number of eosinophils (/10 h.p.f.) in the bronchi and bronchioles was increased from 43.5 +/- 16.8 to 154.8 +/- 21.7 (P < 0.0001) and from 34.8 +/- 0.7 to 106.0 +/- 26.6 (P < 0.01), respectively. This eosinophil infiltration was similarly observed 24 h later. 4. Next, we examined the effects of eosinophil infiltration induced by Lyso-PC on Rrs. Inhalation of Lyso-PC caused a slow increase in Rrs and the percentage increase in Rrs was 19.8 +/- 1.9% (P < 0.0001) 6 h later. Eosinophil infiltration and an increase in Rrs did not occur after inhalation of physiological saline. These phenomena induced by Lyso-PC were diminished by pretreatment with dexamethasone (6 micro g/kg per day for 3 days). 5. Lysophosphatidylcholine causes eosinophil infiltration and a subsequent increase in resistance in airways. Our results indicate that Lyso-PC may be involved in the pathophysiology of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008962     DOI: 10.1111/j.1440-1681.2004.03973.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

1.  Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Authors:  Ying Lai; Rob C Oslund; James G Bollinger; William R Henderson; Luis F Santana; William A Altemeier; Michael H Gelb; Teal S Hallstrand
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD.

Authors:  Hiroaki Kume
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel.

Authors:  Xiangdong Zhu; Jonathan Learoyd; Sanober Butt; Lilly Zhu; Peter V Usatyuk; Viswanathan Natarajan; Nilda M Munoz; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

4.  Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model.

Authors:  Preeti Bansal; Naresh Singh; Jayadev Joshi; Naveen Arora; Shailendera N Gaur
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-05-11

Review 5.  Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids.

Authors:  Eva Knuplez; Eva Maria Sturm; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

6.  Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

Authors:  Mark Yoder; Yan Zhuge; Yang Yuan; Oksana Holian; Sherry Kuo; Richard van Breemen; Larry L Thomas; Hazel Lum
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-05       Impact factor: 5.764

7.  Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1.

Authors:  Yan Zhuge; Yang Yuan; Richard van Breemen; Michael Degrand; Oksana Holian; Mark Yoder; Hazel Lum
Journal:  Allergy Asthma Immunol Res       Date:  2013-11-28       Impact factor: 5.764

Review 8.  An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.

Authors:  Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

9.  Lysophosphatidylcholine plays critical role in allergic airway disease manifestation.

Authors:  Preeti Bansal; Shailendera Nath Gaur; Naveen Arora
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.